26. Mai, 2026, 11:00 Uhr : Special Lecture by Prof. Hongbin Han from Peking University 🇨🇳🇪🇺🇩🇪

The New Phase of China Brain Project and Brain Extracellular Space
Prof. Hongbin Han, Peking University Health Science Center

Professor Hongbin Han is a medical imaging scientist whose research focuses on developing advanced MRI-based imaging methods to study the brain’s extracellular space (ECS) and molecular transport in the brain. His work aims to improve the diagnosis and treatment of neurological diseases—such as stroke and glioma—by understanding ECS dynamics and enabling better drug delivery across the blood–brain barrier. 

Abstract:
With the launch of Phase II the China Brain Project, the central lymphatic system (CLS) has been officially incorporated into the research guidelines and key scientific initiatives for the first time in China. As the most technically challenging to detect and characterize structural component within the CLS, the brain extracellular space (ECS) has finally attracted unprecedented attention from the Chinese neuroscience community. At present, neither preclinical nor clinical trials for the treatment of various brain diseases integrate the brain ECS into therapeutic efficacy evaluation indicators. This long-standing omission leads to an incomplete and inadequate understanding of the pathogenesis, disease progression and therapeutic mechanisms underlying neurological disorders. Accordingly, the precision medicine paradigm for brain diseases is deprived of its fundamental theoretical and structural underpinnings. As such, despite substantial research investment, the development efficiency of novel drugs for neurological diseases including Alzheimer’s disease (AD) and stroke remains persistently low, leaving these conditions to pose an enduring and severe threat to human health. This report systematically analyzes the technical bottlenecks that have hindered the integration of the brain’s extracellular space (ECS) into the new drug development and evaluation frameworks of pharmaceutical regulatory authorities. It also comprehensively reviews the latest research advances in the structural characteristics and physiological functions of the ECS. Furthermore, based on a retrospective analysis of recent basic studies on ECS mediated neuromodulation and targeted therapy, this paper discusses the core practical challenges and delineates the technical roadmap for the clinical translation of fundamental ECS research findings.

Follow us